Millennium Management’s IGM Biosciences IGMS Stock Holding History

Millennium Management’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,200	Closed	-$334K	–	6176
2024 Q3	$334K	Sell	20,200 -9,800	-33%	-$107K	﹤0.01%	5127
2024 Q2	$206K	Buy	+30,000	New	+$257K	﹤0.01%	5128
2021 Q4	–	Sell	-30,000	Closed	-$1.97M	–	7065
2021 Q3	$1.97M	Buy	+30,000	New	+$2.3M	﹤0.01%	3942
2021 Q2	–	Sell	-30,000	Closed	-$2.3M	–	6759
2021 Q1	$2.3M	Buy	30,000 +26,000	+650%	+$2.37M	﹤0.01%	3404
2020 Q4	$353K	Buy	+4,000	New	+$281K	﹤0.01%	4450

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management's IGMS Position: Q3 2025 in Review

Millennium Management sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 275,112 shares — an estimated $308K sold.

Millennium Management first reported a position in IGMS in Q3 2019 and held it in 19 quarters. The position peaked at $10.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Millennium Management reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Millennium Management sold 275,112 IGM Biosciences shares in Q3 2025, an estimated $308K.
Millennium Management first reported a position in IGM Biosciences in Q3 2019 and held it in 19 quarters.
Millennium Management's IGM Biosciences position peaked at $10.6M in Q2 2022.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.